| Bioactivity | AR-C67085 (PSB 0413; FPL 67085) is a potent platelet P2T receptor antagonist with an pIC50 value of 8.60. AR-C67085 inhibits ADP-induced platelet aggregation[1][2]. |
| Target | P2T |
| CAS | 164992-25-0 |
| Formula | C14H22Cl2N5O12P3S |
| Molar Mass | 648.24 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Humphries RG, et al. A novel series of P2T purinoceptor antagonists: definition of the role of ADP in arterial thrombosis. Trends Pharmacol Sci. 1995 Jun;16(6):179-81. [2]. Ingall AH, et al. Antagonists of the platelet P2T receptor: a novel approach to antithrombotic therapy. J Med Chem. 1999 Jan 28;42(2):213-20. |
AR-C67085
CAS: 164992-25-0 F: C14H22Cl2N5O12P3S W: 648.24
AR-C67085 (PSB 0413; FPL 67085) is a potent platelet P2T receptor antagonist with an pIC50 value of 8.60. AR-C67085 inhi
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.